Le Lézard
Classified in: Health
Subject: PDT

More Than 100 Patient Groups Form New International Coalition

BALA CYNWYD, Pa., Sept. 25, 2020 /PRNewswire/ -- Today, more than 100 patient groups across 38 countries launched the World Patients Alliance, an international advocacy coalition. The group seeks to give patients a seat at the healthcare policymaking table.

"Too often, healthcare policy fails to consider patients' actual needs," said Hussain Jafri, founding director of the World Patients Alliance and secretary general of Alzheimer's Pakistan. "The World Patients Alliance will work to make health care universally accessible and affordable."

The World Patients Alliance will advocate for policies that ensure equal and affordable access to optimal healthcare, empower patients to express their needs and play a larger role in deciding their treatments, and improve patient education and healthcare literacy.

"The World Patients Alliance unites thousands of advocates across various countries and disease areas," said Andrew Spiegel, chair of the World Patients Alliance and executive director of the Global Colon Cancer Association. "We're eager to help patients make their voices heard and promote policies that will improve their quality of life."

In addition to Jafri and Spiegel, co-founders of the World Patients Alliance include:

About the World Patients Alliance
The World Patients Alliance is the umbrella organization of patients and patients' organizations around the globe. The World Patients Alliance provides the platform to empower and raise the patients' voice for the provision and access to safe, quality and affordable healthcare. We work toward ensuring patients have an active role to play in all the stages of health care that include planning, provision, monitoring, research and evaluation of health services. We represent patients from all world regions and across all disease areas.

Brigit Wolf
(202) 471-4228 ext. 104

SOURCE World Patients Alliance

These press releases may also interest you

26 oct 2020
Corventive Health, a provider of cloud-based and AI technology solutions, announced a partnership with Halfpenny Technologies, an Accumen, Inc. company today. This partnership fortifies Corventive's core capability of delivering clinical insights...

26 oct 2020
Alterity Therapeutics ("Alterity" or "the Company") today announced it has commenced enrolling patients with Multiple System Atrophy (MSA) in its bioMUSE Study in the United States....

26 oct 2020
Trusted health and lifestyle expert, Dr. Yael Varnado gives advice for fall health and wellness. Dr. V is a practicing physician. STAYING WELL Taking better care of ourselves can be as easy as swapping out a light bulb. Choosing the right lighting...

26 oct 2020
Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Evaluation (CDE) of...

26 oct 2020
Drawbridge Health, a healthcare technology company redefining the blood draw experience for both patients and healthcare providers, today announced a further investment from Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") as well as...

26 oct 2020
EdiGene, Inc. ( "Company", or "EdiGene"), today announced the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has accepted for review the Company's Investigational New Drug (IND) application for ET-01,...

News published on 25 september 2020 at 08:33 and distributed by: